Navigate to Other Sector


Healthcare Newsletter – April 2018

Novartis strides forward with more investments in Cell and Gene Therapy
Photo chromatic Contact Lens - Increasing Consumerization of Medical Devices or Technology Breakthrough?
M&A Driven By Persisting Interests in Rare Diseases, albeit with Selectivity
Expanding Geographies in Vaccine Manufacturing
Growing Inclination for Portfolio Reprioritization in Big Pharma

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons